Previous close | 23.86 |
Open | 23.93 |
Bid | 23.69 x 100 |
Ask | 23.75 x 100 |
Day's range | 22.70 - 23.98 |
52-week range | 18.08 - 24.34 |
Volume | |
Avg. volume | 2,365,596 |
Market cap | 7.195B |
Beta (5Y monthly) | 0.53 |
PE ratio (TTM) | 36.51 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ALAMEDA, Calif., February 27, 2024--Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the company’s management team will participate in fireside chats at the following investor conferences in March:
ALAMEDA, Calif., February 06, 2024--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2023, provided an update on progress toward achieving key corporate objectives, and outlined its commercial, clinical and pipeline development milestones.
ALAMEDA, Calif., February 01, 2024--Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the company’s management team will participate in fireside chats at the following investor conferences in February: